| |
| |
| Introduction |
| |
| Neo Cardiab Care, a GROUP CHANDRANS Company is one of India’s fastest growing pharmaceutical companies. And is a major player in the Indian pharmaceuticals sector with the vision of becoming a global entity.
Implementing innovative, long-term strategies for sustainable future growth, examines the key changes in market strategy which will help companies to boost profitability, drive market share and enhance R&D productivity.
Growth in the pharmaceutical industry is currently driven by innovation, the increasing aging population, and emerging geographical markets such as China and India. |
| |
| The Market Outlook |
| |
| Neo Cardiab Care to focuses on niche therapeutic segments of Neurology, Cardiology, Diabetology. The division would take care of sales and marketing of Central Nervous System, Cardiac and Diabetic Drugs. The segregation of separate division, based on therapeutic segments, is aimed at increasing focus and penetration of niche therapeutic products in the domestic and international market. As per market estimates, there lies immense untapped potential and highly expected growth in these segment .The specialty pharmaceutical market under analysis was valued at $52,057m in 2005 with CNS disorders commanding a share of 22% or $11,500m rendering it at the number one position in the market for the same year.Despite high genericization, treatments for cardiovascular disorders generated revenues of $4,600m with anti-hypertensives accounting for $1.2bn or 26%. |
| |
| Why focused on neuro, cardiovascular and diabetic drugs: |
| |
| The company recognized that the market in future is driven in these segments as these are the “Lifestyle Disorders” and also growing at highest rate so planned to focus on these niche therapeutic segments by a dedicated unit “Neo CarDiab Care” for ailing world and country, specifically under the said segment.
|
| |
| India to be the World Capital for Heart Disease |
| |
|
Coronary Artery Disease was considered the number one killer in the Western countries. But in the last few decades, India has emerged as the world capital for heart diseases. There are more people with heart problems in India than anywhere else in the world.
This factor, combined with our notorious reluctance to exercise, the increased prevalence of diabetes, an increase in jobs that are deskbound, and the relative stress of modern urban living, has contributed to the wave of a swelling population of Indians affected with heart problems. All these factors put together lead to a possibility for Indians to have a very high incidence of heart diseases.
It has been estimated that Indians are nearly four times more susceptible to heart attacks than white Americans. According to the World Health Organization (WHO), 60 percent of the world’s cardiac patients will be Indian by 2010. And according to the International Obesity Task Force, a medical NGO that coordinates with the WHO on obesity issues, of all Asians, South Asians have by far the worst problems when it comes to heart disease.
In comparison with the West, South Asians are affected by cardiovascular related problems at a significantly younger age. Nearly 50 percent of cardiovascular related deaths in India occur below the age of 70, compared with about 22 percent in the West. |
